The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

IMMUCELL CORP /DE/ insider acquisitions

Company CIK 0000811641 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
ICCC · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 90-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Tomsche David ScottTomsche David Scottte Boekhorst Paul Francis Olivierte Boekhorst Paul Francis…Tomsche David Scott · November 25, 2025 · Purchase · Common Stock $0.10 par value per shareTomsche David Scott · November 25, 2025 · Purchase · Common Stock $0.10 par value per sharete Boekhorst Paul Francis Olivier · November 7, 2025 · Stock award · Stock Options (right to buy)Nov 7, 2025Nov 25, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

3 dated transactions · 2 of 2 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Nov 25, 2025IMMUCELL CORP /DE/Common Stock $0.10 par value per shareTomsche David ScottPurchase
Nov 25, 2025IMMUCELL CORP /DE/Common Stock $0.10 par value per shareTomsche David ScottPurchase
Nov 7, 2025IMMUCELL CORP /DE/Stock Options (right to buy)te Boekhorst Paul Francis OlivierStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

ICCC · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: PurchaseCommon Stock $0.10 par value per shareNon-derivative security · Code P1,6334.765Value: 7,781.245Currency not specifiedView ↗
Trade: PurchaseCommon Stock $0.10 par value per shareNon-derivative security · Code P1,6334.76Value: 7,773.08Currency not specifiedView ↗
Trade:
te Boekhorst Paul Francis OlivierPresident and CEO · Director
Stock awardStock Options (right to buy)Derivative security · Code A74,2776.1Value: 453,089.7Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →